Presbyopia to impact more than 2 billion people worldwide by 2020, Alcon forecasts

Article

 

Fort Worth, TX-Eyecare professionals (ECPs) can expect to see a spike in the increase in the number of patients experiencing vision issues due to presbyopia, cautioned Alcon in a report issued recently.

Presbyopia affects nearly 1.7 billion people worldwide today, and that number is expected to soar to 2.1 billion by 2020. In the U.S., this population is expected to grow from nearly 111 million to approximately 123 million by 2020, representing an increase of more than 36% of the population within the next 7 years, Alcon said. Therefore, ECPs must be prepared to educate patients about the condition, the need for treatment to correct presbyopia, and what vision correction options are available.

“Conveying that there is no need to compromise vision acuity, comfort, convenience or even appearance is an important first step in empathizing with patients, and helping them understand what vision correction options are available,” said Roy Kline, OD, who practices in Glen Falls, NY.

“Patients rely on us to recommend a solution that corrects their vision issue,” said Victoria Dzurinko, OD, FAAO, of Downington, PA. “It is important that we explain to each presbyopic patient that our ultimate goal when recommending a vision correction option is to balance their visual needs from distance to near.”ODT

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.